Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Medshine Discovery identifies TLR8 agonists for HBV infection

May 6, 2020

Innovation announces new agreement to study inhibitory effects of brilacidin on SARS-CoV-2

May 6, 2020

Vir and Alnylam identify development candidate targeting the SARS-CoV-2 genome

May 6, 2020

CytoDyn requests compassionate use of leronlimab for COVID-19

May 5, 2020

First COVID-19 patient enrolled in ongoing phase III study of AR-301

May 5, 2020

Phase III trial of Solosec for trichomoniasis meets primary endpoint

May 5, 2020

RECCE-327 shows significant antibacterial activity against N. gonorrhoeae bacteria in mice

May 4, 2020

Serum amyloid A may be useful as a marker of COVID-19 severity and prognosis

May 4, 2020

Janssen BioPharma presents new antivirals

May 4, 2020

Thwarting the hijacker: in vitro study gives "blueprint", drug leads for SARS-CoV-2

May 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...